β2 Integrin/ICAM Expression in Crohn's Disease
Authors:
- Michael SargentMSMichael Sargent
- W.Michael GallatinWGW.Michael Gallatin
- 1 February 1998
- journal article
- Published by Elsevier in Clinical Immunology and Immunopathology
- Vol. 86 (2) , 147-160
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Attenuation of the Inflammatory Response in an Animal Colitis Model by Neutrophil Inhibitory Factor, a Novel β2-Integrin AntagonistScandinavian Journal of Gastroenterology, 1996
- A novel leukointegrin, αdβ2, binds preferentially to ICAM-3Immunity, 1995
- Treatment of refractory rheumatoid arthritis with a monoclonal antibody to intercellular adhesion molecule 1Arthritis & Rheumatism, 1994
- Traffic signals for lymphocyte recirculation and leukocyte emigration: The multistep paradigmCell, 1994
- Physiological and Molecular Mechanisms of Lymphocyte HomingAnnual Review of Immunology, 1992
- Regulatory mechanisms in leukocyte adhesion: flexible receptors for sophisticated travelersImmunology Today, 1992
- Characterization of ICAM-2 and evidence for a third counter-receptor for LFA-1.Journal of Experimental Medicine, 1991
- Binding of the integrin Mac-1 (CD11b/CD18) to the third immunoglobulin-like domain of ICAM-1 (CD54) and its regulation by glycosylationCell, 1991
- Adhesion receptors of the immune systemNature, 1990
- CR3 (CD11b/CD18) expresses one binding site for Arg-Gly-Asp-containing peptides and a second site for bacterial lipopolysaccharide.Journal of Experimental Medicine, 1989